Target intelligence / Profile preview

Heparan sulfate proteoglycan co-receptor (HSPG)

Target
HSPG
Molecular classification
Proteoglycan, Glycoprotein, Cell surface receptor
01

Overview

Heparan sulfate proteoglycans (HSPGs) are ubiquitous glycoproteins found on the cell surface and within the extracellular matrix, consisting of a core protein covalently linked to heparan sulfate glycosaminoglycan chains. In the context of viral infections, particularly SARS-CoV-2, HSPGs serve as essential co-receptors that facilitate the initial attachment of the virus to the host cell membrane (Clausen et al., 2020, Cell). The viral spike protein interacts with the negatively charged sulfate groups on the HSPG chains, which promotes a conformational change or increases the local concentration of the virus, allowing it to efficiently engage its primary receptor, Angiotensin-converting enzyme 2 (ACE2). This interaction forms a ternary complex (Spike-HSPG-ACE2) that is critical for viral entry and subsequent infection. Because of this role, HSPGs and their associated interfaces are significant therapeutic targets; heparin and other glycan mimetics are being explored to competitively inhibit viral binding and reduce infectivity. Beyond viral entry, HSPGs are involved in regulating various physiological processes, including inflammation and tumor metastasis, making them versatile but complex targets for drug development.

Other names
Heparan sulfate proteoglycanHSPGSyndecanGlypicanCell surface glycanViral attachment factorHeparan sulfate co-receptor
02

Mechanism of action

Competitive inhibition of viral spike protein binding to host cell surface heparan sulfate proteoglycans, thereby preventing the formation of the ternary complex required for ACE2-mediated viral entry.

03

Biological functions

Viral attachmentCell signalingCell adhesionEndocytosisGrowth factor sequestrationExtracellular matrix organization
04

Disease associations

Infection (Viral)CancerInflammationCardiovascular disease
05

Safety considerations

Risk of hemorrhage and systemic bleedingHeparin-induced thrombocytopenia (HIT)Interference with endogenous growth factor signaling (e.g., FGF, VEGF)Potential disruption of normal extracellular matrix functions
06

Interacting drugs

Heparin

6 more in the full profile.

07

Biomarkers

Syndecan-1 (SDC1) plasma levelsHeparanase-1 (HPSE) activitySoluble heparan sulfate levels

Beyond the preview

Go deeper on Heparan sulfate proteoglycan co-receptor (HSPG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heparan sulfate proteoglycan co-receptor (HSPG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call